Insurance to cover children’s vaccinations in Saudi Arabia through home medical care

Insurance to cover children’s vaccinations in Saudi Arabia through home medical care
The Council of Cooperative Health Insurance has stated that the Consolidated Health Insurance Policy covers child vaccinations through home medical care for 90 days as a precautionary measure amid the coronavirus outbreak. (File/AFP)
Short Url
Updated 26 April 2020

Insurance to cover children’s vaccinations in Saudi Arabia through home medical care

Insurance to cover children’s vaccinations in Saudi Arabia through home medical care
  • Service providers must comply with patient safety and infection control standards

RIYADH: The Council of Cooperative Health Insurance has stated that the Consolidated Health Insurance Policy covers child vaccinations through home medical care for 90 days as a precautionary measure amid the coronavirus outbreak.
Qualified health insurance companies and accredited health care providers have been told to put the order into effect and service providers were urged to survey individuals failing to do the required vaccinations and tell them to get the necessary children’s vaccinations approved by the Ministry of Health.
“The Council has set several criteria that must be adhered to. Qualified health insurance companies are obliged to provide child vaccination service through council-accredited service providers within the medical network of the insured,” said the council’s spokesperson, Yasser Al-Maarek.
Service providers must also comply with patient safety and infection control standards and procedures approved by the relevant regulatory authorities, the spokesperson said.
He called on all qualified insurance companies and accredited health care providers to inform their clients about these procedures. He also urged service providers wishing to provide home medical care to notify the Council’s general secretariat by email ([email protected]) so that the Council can include them in the list of home medical care providers and notify insurance companies.
Al-Maarek called on people with insurance to take advantage of the communication channels provided by the Council for inquiries, feedback, suggestions and complaints. These include telephone (920001177), e-portal (www.cchi.gov.sa), email ([email protected]) and a smartphone application, in addition to the official pages of the Council on the various social media platforms including Twitter and Facebook.


Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
Updated 14 min 23 sec ago

Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
  • It will go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority

RIYADH: Preclinical studies on the first Saudi vaccine against COVID-19 have been completed.

Professor of epidemiology Dr. Iman Almansour, who heads the team of researchers working on the vaccine at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), confirmed to Arab News on Friday that the studies were complete, and said clinical trials would begin as soon as “the proper approvals” had been given.

She did not specify when that is expected to happen.

The Ministry of Education is financing the team’s project. The team’s research paper has been published in the peer-reviewed journal Pharmaceuticals.

The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen.

Dr. Iman Almansour, professor of epidemiology

According to the published paper, the vaccine has so far proven effective, when used on animals, in eliciting antibodies that will target the virus. “The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen,” Dr. Almansour explained.

Dr. Turki Almugaiteeb, director of Healthcare and Life Sciences at RPD Innovations, which runs the National Vaccine and Biomanufacturing Center, told Arab News: “There is a great focus on the results of medical research because of the pandemic. Research can play a great role in developing a vaccine that can be adopted and further developed in the future. We can say that the Kingdom has a strong infrastructure, which can help produce and manufacture a national vaccine.”

Both Almugaiteeb and Almansour stressed that the experimental vaccine will need to go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority.

Prof. Nasser Al-Aqeeli, the deputy minister of education for research and innovation, said the ministry supported programs at the Kingdom’s universities with more than SR500 million ($133.3 million) in 2020.